Furthermore, it is noteworthy that the mechanism of IL-17 action may be more complex than previously imagined, indicating that more in-depth studies are needed to explore its role in myocardial fibrosis, which could provide a foundation for precise targeted treatments for clinical myocardial fibrosis. The gene discussed is IL17A; the disease is Myocardial fibrosis.